Useful Links
FDA Watch: Another First as Agency Approves NGS Oncology Companion Dx for Multiple Therapies
From – Laboratory Industry Report
The FDA made a stir in May by approving a cancer drug (Keytruda (pembrolizumab) PD-1/PD-L1 inhibitor from Merck) administered on the basis of a…
G2 Blog
Decoding Quality Terminology
By Jennifer Dawson, MHA, LSSBB, DLM(ASCP) bio
Quality has been defined as fitness for use, conformance to requirements, the pursuit of excellence and a product or service free of deficiencies …
Sequencing-Based Screening Needed for Therapeutic Stem Cells
From – Diagnostic Testing & Emerging Technologies
One of the potential therapeutic advantages of stem cells is that they can regenerate. But, a new study, published May 11 in Nature, suggests that the longer…
Theranos and Walgreens Bury the Hatchet—For Now
From – G2 Compliance Advisor
It all looked so promising back in 2015. Privately-held Theranos was poised to usher in a new era of diagnostics with its revolutionary fingerprick technology for…
Employment Law Update for August 2017
By Mike O’Brien bio
Here is my periodic update prepared for interested HR professionals trying to deal with the complex American employment laws…
Help Your Lab Brace for Key Medicare Outpatient Reimbursement Changes
From – G2 Compliance Advisor
With the 2018 Clinical Laboratory Fee Schedule (CLFS) still in the works, CMS proposed changes to the Hospital Outpatient Prospective Payment System (HOPPS) rules on…